연구성과로 돌아가기

2024 연구성과 (215 / 286)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
WoS SCOPUS Document Type Document Title Abstract Authors Affiliation ResearcherID (WoS) AuthorsID (SCOPUS) Author Email(s) Journal Name JCR Abbreviation ISSN eISSN Volume Issue WoS Edition WoS Category JCR Year IF JCR (%) FWCI FWCI Update Date WoS Citation SCOPUS Citation Keywords (WoS) KeywordsPlus (WoS) Keywords (SCOPUS) KeywordsPlus (SCOPUS) Language Publication Stage Publication Year Publication Date DOI JCR Link DOI Link WOS Link SCOPUS Link
Article Endotracheal tube cuff rupture during anesthesia in 2 dogs; [Rupture du ballonnet du tube endotrachéal pendant l'anesthésie chez 2 chiens] A 15-year-old intact male dachshund dog weighing 4.3 kg and a 5-year-old intact male mixed-breed dog weighing 13.6 kg were referred for examination because of paraparesis and facial paralysis, respectively. Magnetic resonance imaging (MRI) of the thoracolumbar region and brain was performed. The dogs were premedicated with IV butorphanol, 0.2 mg/kg body weight (BW) and midazolam, 0.2 mg/kg BW. Anesthesia was induced with IV propofol, 4 to 5 mg/kg BW and maintained with sevoflurane in oxygen. The dachshund was orotracheally intubated with a 5.0-millimeter internal diameter endotracheal (ET) tube. During positioning in the MRI room, intermittent positive pressure ventilation (IPPV) was applied. The mixed-breed dog was orotracheally intubated with a 6.0-millimeter internal diameter ET tube. After inflation of the ET tube cuff, a leaking test was done by applying positive pressure ventilation. In both dogs, a distinct "popping" sound was heard when positive pressure was applied, after which air leakage from the cuff was evident. Failure to inflate the pilot balloon led to suspicion of a ruptured cuff. Reintubation was completed, both dogs remained stable during anesthesia, and no postanesthetic complications were observed. Rupture of both cuffs, which was visually confirmed, was thought to be caused by overinflation of the cuff, repeated sterilization of the ET tubes, and positive pressure ventilation. Repeated sterilization of ET tubes with ethylene oxide can alter the physical integrity of cuffs. Care should be taken not to overinflate ET tube cuffs, especially when they have been repeatedly sterilized, as cuff rupture may result in failure to provide adequate IPPV. © 2024 Canadian Veterinary Medical Association. All rights reserved. Shin, Chi Won; Jang, Min Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive, Saskatoon, S7N 5B4, SK, Canada; Department of Veterinary Surgery, College of Veterinary Medicine, Kyungpook National University, Daegu, 41566, South Korea 57194446715; 55341507600 jangmin@knu.ac.kr; Canadian Veterinary Journal CAN VET J 0008-5286 0008-5286 65 4 SCIE VETERINARY SCIENCES 2024 1 62.1 0 2025-05-07 0 Anesthesia; Animals; Brain; Dogs; Intubation, Intratracheal; Male; Sevoflurane; alanine aminotransferase; alkaline phosphatase; butorphanol; gamma glutamyltransferase; lubricating agent; midazolam; propofol; sevoflurane; silgreen cream; sevoflurane; anesthesia; anesthesia induction; Article; blood biochemistry; cardiomegaly; dachshund (dog); endotracheal intubation; endotracheal tube cuff rupture; eyelid reflex; facial droop; facial nerve paralysis; heart auscultation; hypersalivation; hypertransaminasemia; intermittent positive pressure ventilation; limb weakness; male; neurologic examination; nonhuman; nuclear magnetic resonance imaging; paraplegia; physical examination; platelet count; rupture; thorax radiography; thrombocytosis; animal; brain; case report; dog; endotracheal intubation; veterinary medicine English Final 2024 바로가기 바로가기
Article Original article In vitro antibacterial and antibiofilm effects of mupirocin spray against Staphylococcus pseudintermedius Mupirocin is an effective antibiotic for infectious skin diseases. However, mupirocin is formulated as an ointment and is difficult to apply in canine systemic pyoderma. Therefore, many clinicians reformulate mupirocin off-label ointment into a spray. This study aimed to evaluate the antibacterial and antibiofilm effects of different concentrations of mupirocin spray (2%, 1%, and 0.5%) on Staphylococcus pseudintermedius over 21 days. Mupirocin spray was prepared by mixing mupirocin ointment and distilled water. The antibacterial effects were evaluated by measuring the optical density using broth microdilution assay and by live/dead staining. The antibiofilm activity of mupirocin spray was measured using a crystal violet staining method. All concentrations of mupirocin spray inhibited the growth of S. pseudintermedius. Mupirocin spray also inhibited biofilm formation of each isolate, although the degree of inhibition was influenced by the mupirocin concentration. The antibacterial and antibiofilm effects of mupirocin spray were maintained for 21 days. The 2% and 1% mupirocin sprays exhibited significantly better antibacterial and antibiofilm efficacy than the 0.5% mupirocin spray. Thus, 1-2% mupirocin spray may be effective for clinical use. Mupirocin spray is convenient and effective for the treatment of canine systemic pyoderma caused by S. pseudintermedius infection. Lee, H. J.; Bae, S. G. Kyungpook Natl Univ, Coll Vet Med, Dept Vet Internal Med, 80 Daehak Ro, Daegu 41566, South Korea 59501494000; 59461572500 sgbae@knu.ac.kr; POLISH JOURNAL OF VETERINARY SCIENCES POL J VET SCI 1505-1773 2300-2557 27 4 SCIE VETERINARY SCIENCES 2024 1 62.1 0 2025-05-07 0 0 antibacterial; antibiofilm; canine; mupirocin; spray; Staphylococcus pseudintermedius CANINE SUPERFICIAL PYODERMA; BIOFILM-FORMATION; RESISTANCE antibacterial; antibiofilm; canine; mupirocin; spray; Staphylococcus pseudintermedius Animals; Anti-Bacterial Agents; Biofilms; Dog Diseases; Dogs; Microbial Sensitivity Tests; Mupirocin; Staphylococcus; Staphylococcus pseudintermedius; bacterial DNA; bacterial RNA; crystal violet; distilled water; mupirocin; RNA 16S; antiinfective agent; mupirocin; antibacterial activity; antibiofilm activity; Article; bacterium isolate; broth dilution; controlled study; DNA sequence; fluorescence microscopy; gene sequence; in vitro study; nonhuman; Staphylococcus pseudintermedius; animal; biofilm; dog; dog disease; drug effect; drug therapy; microbial sensitivity test; microbiology; Staphylococcus; Staphylococcus pseudintermedius English 2024 2024 10.24425/pjvs.2024.151746 바로가기 바로가기 바로가기 바로가기
Article Post-Neutron Mass Yield Distribution in the Epi-Cadmium Neutron-Induced Fission of ²³³U Post-neutron mass yield distribution in the epi-cadmium neutron-induced fission of 233U has been carried out by measuring the cumulative yields of various fission products within the mass ranges of 77 to 117 and 123 to 153 using an off-line gamma-ray spectrometric technique. Independent yields of a few fission products were also measured by using the same technique. Charge distribution correction has been applied on cumulative yields to obtain the post-neutron mass yields. The mass yield distribution parameters such as full-width at tenth-maximum of light and heavy mass wings, the average light mass and heavy mass , and the average number of neutrons were obtained. The spectrum average neutron energy is 1.9 MeV. Thus, the role of excitation energy on the nuclear structure effect was examined by comparing the mass yield data in between the epi-cadmium and thermal neutron-induced fission of 233U. Naik, H.; Dange, S. P.; Singh, R. J.; Jang, W. Bhabha Atom Res Ctr, Radiochem Div, Mumbai 400085, India; Kyungpook Natl Univ, Dept Phys, Daegu 41566, South Korea 7005890232; 6602557752; 24322531600; 59777352500 naikhbarc@yahoo.com; NUCLEAR SCIENCE AND ENGINEERING NUCL SCI ENG 0029-5639 1943-748X 198 8 SCIE NUCLEAR SCIENCE & TECHNOLOGY 2024 1.3 62.2 1.01 2025-04-16 2 2 U-233(n,f) reaction; <E-n>=1.9 MeV; measured fission product yields; off-line gamma-ray spectrometric technique; mass chain yield distribution parameters LOW-ENERGY FISSION; CHARGE-DISTRIBUTION; PRODUCTS; SYSTEMATICS; TH-232 <sup>233</sup>U(n,f) reaction; <E<sub>n</sub>> = 1.9 MeV; mass chain yield distribution parameters; measured fission product yields; off-line gamma-ray spectrometric technique Cadmium; Fission products; Fission reactions; Gamma ray spectrometers; Neutron spectrometers; Spectrometry; 233U(n,f) reaction; <En> = 1.9 MeV; Distribution parameters; Fission product yields; Gamma-rays; Mass chain yield distribution parameter; Measured fission product yield; Neutron-induced fission; Off-line gamma-ray spectrometric technique; Spectrometric techniques; Neutrons English 2024 2024-08-02 10.1080/00295639.2023.2259746 바로가기 바로가기 바로가기 바로가기
Article Post-Neutron Mass Yield Distribution in the Epi-Cadmium Neutron-Induced Fission of ²³⁸Pu The cumulative and independent yields of various fission products within the mass range of 78 to 157 have been measured in the epi-cadmium neutron-induced fission of Pu-238 by using an off-line ?-ray spectrometric technique. The lower yield of I-136 than the usual trend indicates the formation of delayed neutron emitter I-137. From the cumulative yields, post-neutron mass chain yields were obtained by using the charge distribution correction. From the mass yield data, the peak-to-valley (P/V) ratio, the full-width at tenth-maximum of light and heavy mass wings, the average light mass and heavy mass as well as the average number of neutrons emitted were obtained. The mass chain yield data in the Pu-238(n,f) reaction were compared with similar data of the Pu-238(n(th),f) reaction to examine the role of excitation energy on the nuclear structure effect and P/V ratio. Naik, H.; Singh, R. J.; Dange, S. P.; Jang, W. Bhabha Atom Res Ctr, Radiochem Div, Mumbai 400085, India; Kyungpook Natl Univ, Daegu 41566, South Korea 7005890232; 24322531600; 6602557752; 59777352500 naikhbarc@yahoo.com; NUCLEAR SCIENCE AND ENGINEERING NUCL SCI ENG 0029-5639 1943-748X 198 4 SCIE NUCLEAR SCIENCE & TECHNOLOGY 2024 1.3 62.2 1.52 2025-04-16 3 3 238Pu(nf) reaction; & lt;En & gt;=1.9 MeV; measured fission product yields; mass chain yield distribution; off-line & gamma;-ray spectrometric technique CHARGE-DISTRIBUTION; REACTOR; U-238 238Pu(n,f) reaction; <En> = 1.9 MeV; mass chain yield distribution; measured fission product yields; off-line γ-ray spectrometric technique Cadmium; Fission products; Fission reactions; Gamma ray spectrometers; Spectrometry; 238pu(n,f) reaction; <en> = 1.9 MeV; Fission product yields; Low-yield; Mass chain yield distribution; Measured fission product yield; Neutron-induced fission; Off-line γ-ray spectrometric technique; Peak-to-valley ratios; Spectrometric techniques; Neutrons English 2024 2024-04-02 10.1080/00295639.2023.2224274 바로가기 바로가기 바로가기 바로가기
Article Post-Neutron Mass Yield Distribution in the Epi-Cadmium Neutron-Induced Fission of ²³⁹Pu In the epi-cadmium neutron-induced fission of Pu-239, cumulative and independent yields of various fission products within the mass ranges of 83 to 117 and 123 to 156 have been measured by using an off-line gamma-ray spectrometric technique. The spectrum average neutron energy is 1.9 MeV. Charge distribution correction on the cumulative yields was applied to obtain their post-neutron mass yields. Mass yield distribution parameters such as the peak-to-valley (P/V) ratio, the full-width at tenth-maximum of light and heavy mass wings, the average light mass and heavy mass , and the average neutron number were obtained. The mass yields in the epi-cadmium and thermal neutron-induced fission of Pu-239 were compared to examine the role of excitation energy on the P/V ratio and the nuclear structure effect. Naik, H.; Singh, R. J.; Dange, S. P.; Jang, W. Bhabha Atom Res Ctr, Radiochem Div, Mumbai 400085, Maharashtra, India; Kyungpook Natl Univ, Dept Phys, Daegu 41566, South Korea 7005890232; 24322531600; 6602557752; 59777352500 naikhbarc@yahoo.com; NUCLEAR SCIENCE AND ENGINEERING NUCL SCI ENG 0029-5639 1943-748X 198 11 SCIE NUCLEAR SCIENCE & TECHNOLOGY 2024 1.3 62.2 1.01 2025-04-16 2 2 Pu-239(n, f) reaction; < e(n)>==1.9 MeV; fission product yields; mass chain yield distribution; off-line gamma-ray spectrometric technique CHARGE-DISTRIBUTION; U-238; ENERGIES <sup>239</sup>Pu(n, f) reaction; <e<sub>n</sub>≥ = 1.9 MeV; fission product yields; mass chain yield distribution; off-line gamma-ray spectrometric technique Fission products; Fission reactions; Gamma ray spectrometers; Neutrons; Spectrometry; 239pu(n, f) reaction; <en≥ = 1.9 MeV; Fission product yields; Gamma-rays; Mass chain yield distribution; Neutron-induced fission; Off-line gamma-ray spectrometric technique; Peak-to-valley ratios; Spectra's; Spectrometric techniques; Cadmium English 2024 2024 10.1080/00295639.2024.2303541 바로가기 바로가기 바로가기 바로가기
Article Research on natAg(γ,xn)103-106Ag reaction cross sections with the bremsstrahlung end-point energy of 70 and 75 MeV The flux -weighted average cross sections ofnatAg(gamma,xn)103-106Ag reactions were measured with the bremsstrahlung end -point energy of 70 and 75 MeV using an activation and off-line gamma-ray spectrometric technique. The GEANT4 code was used for the simulation of the bremsstrahlung spectra. The cross sections of natAg(gamma,xn) 103106Ag reactions as a function of mono -energetic photons were theoretically calculated by using the TALYS-1.96 code. The data of the present work and literature at different bremsstrahlung end -point energy are found to be in agreement with the theoretical values within the uncertainty limit. It can be seen that the flux -weighted average cross sections of the natAg(gamma,xn)105.106Ag reactions increase with bremsstrahlung energy up to the Giant Dipole Resonance region. Thereafter, a small decrease trend with the bremsstrahlung energy was seen due to the opening of another reaction channel. Naik, Haladhara; Kim, Guinyun; Jang, Wooyoung; Tatari, Mansoureh; Nguyen, Thi Hien; Kye, Yong Uk; Cho, Moo-Hyun Kyungpook Natl Univ, Ctr High Energy Phys, Daegu 41566, South Korea; Bhabha Atom Res Ctr, Radiochem Div, Mumbai 400085, India; Univ Texas Arlington, Phys Dept, Arlington, TX 76019 USA; Yazd Univ, Phys Dept, Yazd 8915818411, Iran; Dongnam Inst Radiol & Med Sci, Med Radiat Phys Lab, Busan 46033, South Korea; Pohang Univ Sci & Technol, Div Adv Nucl Engn, Pohang 37673, South Korea Tatari, Mansoureh/AAV-2188-2021 7005890232; 35313854400; 57197062363; 55826668500; 57201066391; 56020858600; 17136702900 gnkim@knu.ac.kr; NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS NUCL INSTRUM METH B 0168-583X 1872-9584 550 SCIE INSTRUMENTS & INSTRUMENTATION;NUCLEAR SCIENCE & TECHNOLOGY;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL;PHYSICS, NUCLEAR 2024 1.3 62.2 0 2025-05-07 0 0 NatAg(gamma xn)103-106Ag reaction cross sections; Bremsstrahlung end-point energy of 70 and 75; MeV; Activation and off-line gamma-ray spectrometric; technique; TALYS-1.96 code NUCLEAR-DATA; RESONANCE <sup>Nat</sup>Ag(γ,xn)<sup>103-106</sup>Ag reaction cross sections; Activation and off-line γ-ray spectrometric technique; Bremsstrahlung end-point energy of 70 and 75 MeV; TALYS-1.96 code Codes (symbols); Gamma ray spectrometers; Spectrometry; Statistical methods; Activation and off-line γ-ray spectrometric technique; Bremsstrahlung end-point energy of 70 and 75 MeV; End-points; Energy; Natag(γ,xn)103-106ag reaction cross section; Point energies; Reaction cross-section; Spectrometric techniques; TALYS-1.96 code; Weighted averages; Chemical activation English 2024 2024-05 10.1016/j.nimb.2024.165305 바로가기 바로가기 바로가기 바로가기
Article Severe Fever with Thrombocytopenia Syndrome in South Korea, 2016-2021: Clinical Features of Severe Progression and Complications Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infection with a high case fatality rate. The serious clinical features need to be further defined. We performed a retrospective analysis among SFTS patients in South Korea during 2016-2021 to update the current status. The basic epidemiology of all reported cases was analyzed, and the detailed clinical data of the subjects were further collected from study hospitals selected in terms of their geographic location and capability of SFTS care. Cases of SFTS were reported across the country and were greatly increased since the initial endemic phase, even under the passive surveillance system. The case fatality rate remained at approximately 16.8%. Coinfections at admission were present in 7.8% of the patients. Major complications included bleeding (15.2%), hemophagocytic lymphohistiocytosis (6.7%), bacteremia or candidemia (4.0%), and invasive pulmonary aspergillosis (1.7%). It took a median 4 days from the onset of illness to hospital admission. Rapid clinical deterioration was observed with a median 1 day for intensive care unit admission, 3 days for mechanical ventilation, 4 days for renal replacement therapy, and 5 days for death, all after the hospitalization. Multivariate analysis showed that the fatality was associated with older age, bacteremia, or candidemia during hospitalization, and the presence of several variables at admission such as fever, altered mentality, aspartate aminotransferase >200 IU/L, serum creatinine level >1.2 mg/dL, and prolonged prothrombin time and activated partial thromboplastin time. Treatment options to improve clinical outcomes are limited, despite best supportive care. Specific treatment is urgently needed to change the fatal course. Lee, Minkyeong; Lee, Eunyoung; Kim, Shin-Woo; Kim, Young Keun; Bae, In-Gyu; Kim, Jinyeong; Lee, Seung Soon; Lee, Hyo-Jin; Lee, Chang-Seop; Jun, Jae-Bum; Kim, Hyun Ah; Jeon, Min Hyok; Kim, Yeon-Sook; Song, Eun Hee; Jung, Sook-In; Baik, Seung Hee; Kim, Dong-Min; Kim, Namhee; Bang, Jihwan; Park, Sang-Won Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; Boramae Med Ctr, Seoul, South Korea; Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; Yonsei Univ, Dept Internal Med, Coll Med, Wonju, South Korea; Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Internal Med, Coll Med, Jinju, South Korea; Hanyang Univ, Dept Internal Med, Guri Hosp, Guri, South Korea; Hallym Univ Chuncheon Sacred Heart Hosp, Dept Internal Med, Chunchon, South Korea; Catholic Univ Korea, Div Infect Dis, Dept Internal Med, Coll Med, Seoul, South Korea; Jeonbuk Natl Univ, Dept Internal Med, Med Sch, Jeonju, South Korea; Univ Ulsan, Coll Med, Dept Internal Med, Ulsan Univ Hosp, Ulsan, South Korea; Keimyung Univ, Dept Infect Dis, Sch Med, Daegu, South Korea; Soonchunhyang Univ, Soonchunhyang Univ Cheonan Hosp, Dept Internal Med, Coll Med,Div Infect Dis, Cheonan, South Korea; Chungnam Natl Univ, Sch Med, Dept Internal Med, Daejeon, South Korea; GangNeung Asan Hosp, Dept Internal Med, Kangnung, South Korea; Chonnam Natl Univ, Sch Med, Dept Infect Dis, Gwangju, South Korea; Cheju Halla Hosp, Dept Internal Med, Jeju, South Korea; Chosun Univ, Dept Internal Med, Coll Med, Gwangju, South Korea; Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; Boramae Med Ctr, Seoul, South Korea JUNG, SOOK IN/AGO-2862-2022; JY, LEE/GRS-9767-2022; kim, dongmin/MEO-8165-2025; Park, Sang-Won/M-6366-2017; bu, ji/JUU-6900-2023; Kim, Sun/GSN-4867-2022 57221697425; 7003690974; 8710731500; 35322538300; 7004882611; 57222440773; 56386309200; 57371176600; 26423010200; 56402582300; 57059615500; 10439278500; 57208777401; 7101904230; 7403676835; 57220658376; 39861468000; 55696791500; 59804832100; 56108350600 hswon1@snu.ac.kr; AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE AM J TROP MED HYG 0002-9637 1476-1645 111 3 SCIE PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH;TROPICAL MEDICINE 2024 1.6 62.5 0.71 2025-05-07 1 2 SYNDROME VIRUS; ASPERGILLOSIS; PREVALENCE Adult; Aged; Aged, 80 and over; Bacteremia; Disease Progression; Female; Hemorrhage; Humans; Male; Middle Aged; Phlebovirus; Republic of Korea; Retrospective Studies; Severe Fever with Thrombocytopenia Syndrome; alanine aminotransferase; aspartate aminotransferase; C reactive protein; corticosteroid; creatine kinase; creatinine; hemoglobin; lactate dehydrogenase; prednisolone; ribavirin; steroid; thromboplastin; activated partial thromboplastin time; aged; Article; artificial ventilation; aspergillosis; bacteremia; bleeding; candidemia; case fatality rate; clinical feature; clinical outcome; creatinine blood level; female; fever; geographic distribution; hemophagocytic syndrome; hospital admission; hospitalization; human; intensive care unit; major clinical study; male; mortality rate; multivariate analysis; outcome assessment; partial thromboplastin time; plasma exchange; polymerase chain reaction; prothrombin time; retrospective study; reverse transcription polymerase chain reaction; risk factor; thrombocytopenia; urea nitrogen blood level; very elderly; adult; bacteremia; bleeding; disease exacerbation; epidemiology; etiology; microbiology; middle aged; mortality; Phlebovirus; severe fever with thrombocytopenia syndrome; South Korea English 2024 2024-09 10.4269/ajtmh.24-0062 바로가기 바로가기 바로가기 바로가기
Article A simulation and scheduling method for analyzing the peak time capacity of the dual-robot in-line stocker The automated material handling system (AMHS) plays a central role in realising smart manufacturing by providing manufacturing facilities with flexible, fast, and precise controls. This paper investigates a new type of AMHS known as the in-line stocker, which not only moves unit loads in manufacturing facilities under processing, similar to the automated-guided vehicle but also stores them on shelves, similar to the automated storage and retrieval system, which can reduce material handling space requirements. However, the traffic rate is very high inside an in-line stocker, and two robots are used along the single lane, which is the dual-robot in-line stocker (DRIS). This paper develops an analytical model to estimate the capacity of the DRIS based on a combined simulation and scheduling method. The simulation analysis shows that the model can be used not only to estimate the precise capacity of a DRIS but also to optimise its operating parameters. © 2023 The Operational Research Society. Chung, Jaewoo Department of Operations Management, School of Business Administration, Kyungpook National University-Daegu, Daegu, South Korea 55470448800 chung@knu.ac.kr; Journal of Simulation J SIMUL 1747-7778 1747-7786 18 5 SCIE COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;OPERATIONS RESEARCH & MANAGEMENT SCIENCE 2024 1.7 62.7 0.4 2025-04-16 1 automated material handling system; Dual-robot in-line stocker system; material handling; simulation model Automatic guided vehicles; Industrial robots; Mobile robots; Automated material handling systems; Dual robots; Dual-robot in-line stocke system; Flexible control; Manufacturing facility; Material handling; Peak time; Scheduling methods; Simulation model; Smart manufacturing; Materials handling English Final 2024 10.1080/17477778.2023.2214685 바로가기 바로가기 바로가기
Article An acoustic bellows-type round window transducer for middle-ear implants Background: This study describes the development of output devices for round window middle-ear. To overcome the problems of output devices that apply sound pressure directly to the round window, an acoustic bellows-type round window transducer was implemented by combining a small bellows, acoustic tube, and balanced armature driver. Methods: The output characteristics of the proposed acoustic bellows-type round window transducer were confirmed through bench tests and distortion measurements. To compare the vibration transmission characteristics of the proposed transducer with those of sound pressure stimulation devices, an experiment was performed using four human temporal bones. Findings: The average output magnitude of the acoustic bellows-type round window transducer was equivalent to sound pressure levels of 92, 96, and 108 dB for frequency ranges of 2 kHz, respectively. The results showed that the proposed transducer delivered vibration consistently without reducing the sound pressure level due to leakage, unlike the sound pressure stimulation device. Interpretation: Therefore, the acoustic bellows-type round window transducer is a more stable and suitable output device for round window middle-ear implants than a sound pressure stimulation device. It is expected to overcome the limitations of sound pressure stimulation devices and to contribute to new technical solutions in the field of round window middle-ear implants development. Shin, Dong Ho; Lee, Kyu-Yup; Seong, Ki Woong Kyungpook Natl Univ, Inst Biomed Engn Res, Daegu 41944, South Korea; Kyungpook Natl Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu 41944, South Korea; Kyungpook Natl Univ Hosp, Dept Biomed Engn, Daegu 41944, South Korea 56693502600; 22135779500; 23968197900 seongkw@ee.knu.ac.kr; CLINICAL BIOMECHANICS CLIN BIOMECH 0268-0033 1879-1271 120 SCIE ENGINEERING, BIOMEDICAL;ORTHOPEDICS;SPORT SCIENCES 2024 1.4 62.9 0 2025-05-07 0 0 Round window middle-ear implants; Acoustic bellows-type transducer; Balanced armature driver; Vibration; Cadaveric experiments VIBRANT SOUNDBRIDGE DEVICE; FLOATING MASS TRANSDUCER; MIXED HEARING LOSSES; AID; HISTORY Acoustic bellows-type transducer; Balanced armature driver; Cadaveric experiments; Round window middle-ear implants; Vibration Acoustics; Ear, Middle; Equipment Design; Humans; Ossicular Prosthesis; Pressure; Round Window, Ear; Sound; Temporal Bone; Transducers; Vibration; Acoustic intensity measurement; Acoustic noise; Acoustic noise measurement; Acoustic transducers; Cadaveric experiments; Ear protectors; Pressure transducers; Acoustic bellow-type transducer; Balanced armature driver; Middle ear implants; Output devices; Pressure stimulation; Round window middle-ear implant; Sound pressures; Sound pressures level; Stimulation devices; Vibration; adult; Article; auditory stimulation; cochlea fenestra; comparative study; controlled study; equipment design; human; middle ear; sound pressure; temporal bone; vibration; acoustics; middle ear prosthesis; physiology; pressure; sound; surgery; transducer; Bellows English 2024 2024-12 10.1016/j.clinbiomech.2024.106349 바로가기 바로가기 바로가기 바로가기
Review Characteristics and Effectiveness of Individual Psychotherapy for Palliative and End-of-Life Care: A Literature Review for Randomized Controlled Trials Objective The introduction of psychotherapy in palliative and end-of-life care settings has become increasingly common and is effective in decreasing many psychological problems. This review reports the characteristics and effectiveness of individual psychotherapeutic interventions for patients receiving palliative and end-of-life care. In addition, the review reports the effectiveness of psychotherapies considering the expected life expectancy. Methods The PubMed, Google Scholar, and Cochrane Library databases were searched for English-language articles published between January 2000 to May 2023. Results Twenty-six studies were included and classified into a total of nine types of psychotherapies, namely, dignity therapy (DT), life review therapy, narrative therapy, managing cancer and living meaningfully (CALM), individual meaning-centered psychotherapy, meaning and purpose therapy, meaning-making therapy, meaning-of-life therapy, and cognitive therapy. Conclusion Most of the psychotherapies provided to patients receiving palliative and end-of-life care showed effectiveness in the reduction of negative emotions and positive factors related to end-of-life issues. Most studies targeted patients with advanced cancer; however, studies on DT did not limit the target group to patients with cancer. Considering the expected life expectancy, CALM was found to be suitable for patients receiving early palliative care. Psychiatry Investig 2024;21(5):433-448 Kim, Kyungmin; Woo, Jungmin Kyungpook Natl Univ, Sch Med, Dept Psychiat, 130 Dongdeok Ro, Daegu 41944, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Dept Psychiat, Daegu, South Korea; Kyungpook Natl Univ Hosp, Dept Psychiat, Daegu, South Korea 57201480192; 56241307600 woojm3@hanmail.net; PSYCHIATRY INVESTIGATION PSYCHIAT INVEST 1976-3026 21 5 SCIE;SSCI PSYCHIATRY 2024 1.8 63.0 0.3 2025-05-07 0 1 Psychotherapy; Palliative care; Terminal care; Review COGNITIVE-BEHAVIORAL THERAPY; TERMINALLY-ILL PATIENTS; ADVANCED CANCER; DIGNITY THERAPY; PSYCHOLOGICAL ADJUSTMENT; MEANING-MAKING; OVARIAN-CANCER; PILOT; INTERVENTION; DEPRESSION Palliative care; Psychotherapy; Review; Terminal care anxiety; aromatherapy; cancer chemotherapy; cognitive therapy; data base; depression; emotional stress; fatigue; follow up; Hospital Anxiety and Depression Scale; human; insomnia; life expectancy; narrative therapy; outcome assessment; palliative therapy; psychotherapy; quality of life; randomized controlled trial (topic); Review; socioeconomics; systematic review; terminal care English 2024 2024-05 10.30773/pi.2023.0357 바로가기 바로가기 바로가기 바로가기
Article Development and Validation of the Mental Health Scale for Maltreated Children Objective This study aimed to develop and validate a comprehensive self-report questionnaire to assess emotional and behavioral problems and psychological trauma in maltreated children. Methods The Mental Health Scale for Maltreated Children (MHS-MC) was constructed to encompass five major symptoms (depression, anxiety, inattention/hyperactivity/impulsivity, aggression/defiance, and psychological trauma) prevalent in maltreated children. Critical items and ego-resilience subscale were also devised to increase clinical utility. After informed consent, 205 children (maltreated children, n=157, 76.6%) were recruited nationwide, and they answered a package of self-report measures, including the MHS-MC. Reliability, construct validity, concurrent validity, and criterion-related validity were examined to explore the psychometric properties. Results The reliability was good to excellent. Confirmatory factor analysis yielded a five-factorial solution for the symptom subscales supporting construct validity. In logistic regression, the total scores of the MHS-MC predicted membership in the maltreated group. Criterion-related validity was generally satisfactory in that all subscales of the MHS-MC showed significant correlations with relevant measures in the expected direction. Conclusion This is the first attempt to develop a comprehensive psychological scale based on nationwide data collected from maltreated Korean children. We hope that the continued standardization of this scale will contribute to evidence-based clinical and policy decisionmaking for maltreated children. Psychiatry Investig 2024;21(3):242-254 Kim, Bin -Na; Jo, Hyeseon; Kang, Suhyeon; Kim, Soo-Yeon; Park, Ha-young; Park, Jungkyu; Kang, Hyo Shin Gachon Univ, Dept Psychol, Seongnam, South Korea; Natl Ctr Rights Child, Child Protect Off, Seoul, South Korea; Kyungpook Natl Univ, Dept Psychol, Daegu, South Korea; Kyungpook Natl Univ, Dept Psychol, 80 Daehak Ro, Daegu 41566, South Korea 56125185200; 58959738900; 58959739000; 58960352000; 58959939900; 56206565000; 57219595147 hyoshin.kang@knu.ac.kr;jkp@knu.ac.kr; PSYCHIATRY INVESTIGATION PSYCHIAT INVEST 1976-3026 21 3 SCIE;SSCI PSYCHIATRY 2024 1.8 63.0 0 2025-05-07 0 0 Keywords Child maltreatment; Self report; Psychometrics; Mental health. TRAUMA; PERFORMANCE; ADOLESCENTS; RESILIENCE; SYMPTOMS; DWLS Child maltreatment; Mental health; Psychometrics; Self report adolescent; aggression; anxiety; Article; child; child abuse; child protection; concurrent validity; confirmatory factor analysis; construct validity; criterion related validity; decision making; depression; DSM-5; ego; elementary student; emotional stability; exploratory factor analysis; female; human; hyperactivity; impulsiveness; informed consent; internal consistency; Korean (people); Likert scale; major clinical study; male; maltreated children; mental health; middle school; nightmare; parental consent; personality; pilot study; psychiatrist; psychometry; psychotrauma; rating scale; reliability; self report; validation process; validity English 2024 2024-03 10.30773/pi.2023.0313 바로가기 바로가기 바로가기 바로가기
Article Differences in Depressive Symptom Profile by Age Group in Koreans With Major Depressive Disorder: Results From Nationwide General Population Surveys Objective This study investigated to what extent a range of depressive symptoms was differentially present depending on age group in Korean population. Methods Data was pooled from five nationally representative surveys in which 29,418 respondents aged at least 18 years were interviewed face-to-face using the Korean version of the Composite International Diagnostic Interview. A total of 691 (2.1%) respondents were found to have had at least 1 episode of major depressive disorder (MDD) within the last 12 months. Logistic regression analysis was conducted to identify the association between age groups (18-39 years, 40-59 years, and 60 years or older) and 26 depressive symptoms among the respondents with MDD. Results Associations were observed between somatic symptoms-including insomnia, awakening 2 h earlier-and cognitive symptoms such as feelings of guilt, thoughts of death, and suicidal ideation with the older age group. Whereas, atypical depressive symptoms such as increased appetite, weight gain, and hypersomnia were associated with the younger age group. When adjusted for sociodemographic factors, symptoms such as depressed mood, awakening 2 h earlier, and feeling guilty in the older age group, and hypersomnia, psychomotor retardation, and worse in the morning in the younger age group still remained statistically significant. Furthermore, fatigue and decreased libido were newly associated with the younger age group. Conclusion The findings of this study revealed distinct patterns of symptomatology in MDD based on age groups. These differences should be considered owing to their potential relevance to treatment response and prognosis in the clinical setting. Lee, Jimin; Kim, Byung-Soo; Cho, Seong-Jin; Lee, Jun-Young; Park, Jee Eun; Seong, Su Jeong; Chang, Sung Man Kyungpook Natl Univ, Sch Med, Dept Psychiat, 680 Gukchaebosang Ro, Daegu 41944, South Korea; Kyungpook Natl Univ Hosp, Dept Psychiat, Daegu, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Dept Psychiat, Daegu, South Korea; Gachon Univ, Coll Med, Gil Med Ctr, Dept Psychiat, Incheon, South Korea; Seoul Natl Univ, Coll Med, Dept Psychiat, SMG SNU Boramae Med Ctr, Seoul, South Korea; Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Psychiat, Seoul, South Korea; Kangdong Sacred Heart Hosp, Dept Psychiat, Seoul, South Korea Lee, Jun-Young/N-5963-2019; Kim, Byung-Soo/H-4047-2013; Lee, Jun-Young/J-5604-2012 57219156372; 57214661242; 55572091200; 56117898800; 57222879261; 55079714000; 23092756400 psyjang@hanmail.net; PSYCHIATRY INVESTIGATION PSYCHIAT INVEST 1976-3026 21 9 SCIE;SSCI PSYCHIATRY 2024 1.8 63.0 0 2025-05-07 0 0 Major depressive disorder; Depressive symptoms; Age groups; Korea; Epidemiology YOUNGER ADULTS; OLDER-ADULTS; EPIDEMIOLOGY Age groups; Depressive symptoms; Epidemiology; Korea; Major depressive disorder creatinine; adult; appetite; Article; bipolar disorder; body weight gain; cognition; Depressive Symptom Profile; DSM-IV; education; fatigue; female; health survey; household income; human; hypersomnia; insomnia; Korean (people); libido disorder; logistic regression analysis; major clinical study; major depression; male; middle aged; prevalence; psychomotor retardation; psychosis; questionnaire; restlessness; schizophrenia; suicidal ideation; symptomatology; treatment response English 2024 2024-09 10.30773/pi.2024.0074 바로가기 바로가기 바로가기 바로가기
Article Distinguishing Affective Temperament Profiles in Major Depressive Disorder and Bipolar Disorder Through the Short Version of TEMPS-A: Cross-Sectional Study Using Latent Profile Analysis Objective This study aimed to elucidate the distinct response patterns exhibited by patients diagnosed with bipolar disorder (BD) and those with major depressive disorder (MDD) through the application of the short version of the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Autoquestionnaire (TEMPS-A-SV). Methods A total of 2,458 participants consisting of patients with MDD (n=288), BD (BD I, n=111; BD II, n=427), and control group (n=1,632) completed the TEMPS-A-SV. The response patterns of the participants were classified into distinct profiles using latent profile analysis. The study further examined the impact of covariates such as age, sex, and diagnostic group on derived latent profile memberships. Results The following three latent profiles were identified: High Affective Temperament Group (17.86%), Low Affective Temperament Group (41.25%), and Middle Affective Temperament Group (40.89%). Compared with the patient group with MDD and BD, the control group was more likely to belong in the Low Affective Temperament Group, which showed a higher score on hyperthymic temperament than the Middle Affective Temperament Group. Furthermore, compared with the patients with BD, the MDD patients were more likely to be in the Low Affective Temperament Group rather than the Middle Affective Temperament Group. Conclusion These results indicate that different affective temperaments exist between patients with MDD and BD. Attempting to classify response patterns using the TEMPS-A-SV can help diagnose MDD and BD correctly. Jang, Ha Lim; Lee, Chanhui; Yu, Hyeona; Lee, Daseul; Lee, Hyuk Joon; Ha, Tae Hyon; Kang, Hyo Shin; Myung, Woojae; Park, Jungkyu Kyungpook Natl Univ, Dept Psychol, 80 Daehak Ro, Daegu 41566, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, 82 Gumi Ro 173beon Gil, Seongnam 13620, South Korea; Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea ; Ha, Tae/U-5558-2019; Myung, Woojae/AAD-3016-2021 59245685800; 59245075500; 57910913300; 57973764300; 59147189100; 7203014550; 57219595147; 37099034100; 56206565000 hyoshin.kang@knu.ac.kr;wmyung@snu.ac.kr;jkp@knu.ac.kr; PSYCHIATRY INVESTIGATION PSYCHIAT INVEST 1976-3026 21 6 SCIE;SSCI PSYCHIATRY 2024 1.8 63.0 0 2025-05-07 0 0 Affective temperament; Latent profile analysis; Mood disorder; TEMPS-A-SV SUICIDAL RISK; DIAGNOSIS; VALIDATION; VARIABLES; UNIPOLAR; VALIDITY; FEATURES; MEMPHIS; PISA Affective temperament; Latent profile analysis; Mood disorder; TEMPS-A-SV adult; affective temperament profile; Article; bipolar disorder; controlled study; cross-sectional study; cyclothymia; DSM-IV; entropy; female; hospitalization; human; identifiable information; interview; irritability; major clinical study; major depression; male; mental disease; mini international neuropsychiatric interview; mixed anxiety and depression; mood disorder; psychiatrist; questionnaire; risk factor; self report; temperament; Temperament Evaluation of Memphis, Pisa, Paris and San Diego English 2024 2024-06 10.30773/pi.2023.0444 바로가기 바로가기 바로가기 바로가기
Article Effect of Low-Intensity Transcranial Focused Ultrasound Stimulation in Patients With Major Depressive Disorder: A Randomized, Double-Blind, Sham-Controlled Clinical Trial Objective Low-intensity transcranial focused ultrasound (tFUS) has emerged as a promising non-invasive brain stimulation modality with high spatial selectivity and the ability to reach deep brain areas. The present study aimed to investigate the safety and effectiveness of low-intensity tFUS in treating major depressive disorder. Methods Participants were recruited in an outpatient clinic and randomly assigned to either the verum tFUS or sham stimulation group. The intervention group received six sessions of tFUS stimulation to the left dorsolateral prefrontal cortex over two weeks. Neuropsychological assessments were conducted before and after the sessions. Resting-state functional magnetic resonance imaging (rsfMRI) was also performed to evaluate changes in functional connectivity (FC). The primary outcome measure was the change in depressive symptoms, assessed with the Montgomery-& Aring;sberg Depression Rating Scale (MADRS). Results The tFUS stimulation sessions were well tolerated without any undesirable side effects. The analysis revealed a significant main effect of session sequence on the MADRS scores and significant interactions between the session sequences and groups. The rsfMRI analysis showed a higher FC correlation between the right superior part of the subgenual anterior cingulate cortex (sgACC) and several other brain regions in the verum group compared with the sham group. Conclusion Our results reveal that tFUS stimulation clinically improved MADRS scores with network-level modulation of a sgACC subregion. This randomized, sham-controlled clinical trial, the first study of its kind, demonstrated the safety and probable efficacy of tFUS stimulation for the treatment of depression. Psychiatry Investig 2024;21(8):885-896 Oh, Jooyoung; Ryu, Jin Sun; Kim, Junhyung; Kim, Soojeong; Jeong, Hyu Seok; Kim, Kyung Ran; Kim, Hyun-Chul; Yoo, Seung-Schik; Seok, Jeong-Ho Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Psychiat, 20 Eonju Ro 63 Gil, Seoul 06229, South Korea; Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; Kyungpook Natl Univ, Dept Artificial Intelligence, Daegu, South Korea; Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA ; Kim, Junhyung/ABH-5042-2020; Jeong, Hyu seok/HOC-2008-2023; kim, jong-eun/B-3550-2017 56660176300; 57204267641; 58905985900; 59284803000; 57242337300; 23097922100; 57194876917; 7401970708; 55396063100 yoo@bwh.harvard.edu;johnstein@yuhs.ac; PSYCHIATRY INVESTIGATION PSYCHIAT INVEST 1976-3026 21 8 SCIE;SSCI PSYCHIATRY 2024 1.8 63.0 3.44 2025-05-07 10 10 Focused ultrasound; Neuromodulation; Major depressive disorder; Subgenual anterior cingulate cortex; Dorsolateral prefrontal cortex STATE FUNCTIONAL CONNECTIVITY; MAGNETIC STIMULATION; ELECTROCONVULSIVE-THERAPY; EFFICACY; SAFETY; PET Dorsolateral prefrontal cortex; Focused ultrasound; Major depressive disorder; Neuromodulation; Subgenual anterior cingulate cortex agomelatine; amfebutamone; duloxetine; escitalopram; fluoxetine; mirtazapine; sertraline; venlafaxine; vortioxetine; adult; anxiety; Article; calcification; clinical article; computer assisted tomography; controlled study; dorsolateral prefrontal cortex; double blind procedure; female; functional connectivity; functional magnetic resonance imaging; human; low intensity focused ultrasound; low intensity transcranial focused ultrasound stimulation; major depression; male; Montgomery Asberg Depression Rating Scale; mood; neuroimaging; neuromodulation; neuropsychological assessment; nuclear magnetic resonance imaging; Profile of Mood States; quick inventory of depressive symptomatology; randomized controlled trial; subgenual anterior cingulate cortex; suicidal ideation; T1 weighted imaging; Wechsler adult intelligence scale English 2024 2024-08 10.30773/pi.2024.0016 바로가기 바로가기 바로가기 바로가기
Article Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled Trial Objective This study was performed to evaluate the efficacy and safety of lurasidone (160 mg/day) compared to quetiapine XR (QXR; 600 mg/day) in the treatment of acutely psychotic patients with schizophrenia. Methods Patients were randomly assigned to 6 weeks of double-blind treatment with lurasidone 160 mg/day (n=105) or QXR 600 mg/ day (n=105). Primary efficacy measure was the change from baseline to week 6 in Positive and Negative Syndrome Scale (PANSS) total score and Clinical Global Impressions severity (CGI-S) score. Adverse events, body measurements, and laboratory parameters were assessed. Results Lurasidone demonstrated non-inferiority to QXR on the PANSS total score. Adjusted mean +/- standard error change at week 6 on the PANSS total score was-26.42 +/- 2.02 and-27.33 +/- 2.01 in the lurasidone and QXR group, respectively. The mean difference score was-0.91 (95% confidence interval-6.35-4.53). The lurasidone group showed a greater reduction in PANSS total and negative subscale on week 1 and a greater reduction in end-point CGI-S score compared to the QXR group. Body weight, body mass index, and waist circumference in the lurasidone group were reduced, with significantly lower mean change compared to QXR. Endpoint changes in glucose, cholesterol, triglycerides, and low-density lipoprotein levels were also significantly lower. The most common adverse drug reactions with lurasidone were akathisia and nausea. Conclusion Lurasidone 160 mg/day was found to be non-inferior to QXR 600 mg/day in the treatment of schizophrenia with comparable efficacy and tolerability. Adverse effects of lurasidone were generally tolerable, and beneficial effects on metabolic parameters can be expected. Kim, Se Hyun; Jung, Do-Un; Kim, Do Hoon; Lee, Jung Sik; Lee, Kyoung-Uk; Won, Seunghee; Lee, Bong Ju; Kim, Sung-Gon; Roh, Sungwon; Park, Jong-Ik; Kim, Minah; Jung, Sung Won; Oh, Hong Seok; Jung, Han-yong; Kim, Sang Hoon; Chee, Hyun Seung; Paik, Jong-Woo; Lee, Kyu Young; Kim, Soo In; Lee, Seung-Hwan; Cheon, Eun-Jin; Kim, Hye-Geum; Lee, Heon-Jeong; Chung, In Won; Choi, Joonho; Kim, Min-Hyuk; Cho, Seong-Jin; Youn, Hyunchul; Chang, Jhin-Goo; Song, Hoo Rim; Kim, Euitae; Kim, Won-Hyoung; Kim, Chul Eung; Park, Doo-Heum; Lee, Byung-Ook; Lee, Jungsun; Lee, Seung-Yup; Kang, Nuree; Jung, Hee Yeon Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea; Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; Inje Univ, Busan Paik Hosp, Coll Med, Dept Psychiat, Busan, South Korea; Hallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Dept Psychiat, Chunchon, South Korea; Hallym Univ, Coll Med, Mind Neuromodulat Lab, Chunchon, South Korea; Lee Jung Sik Psychiat Clin, Suwon, South Korea; Catholic Univ Korea, Uijeongbu St Marys Hosp, Dept Psychiat, Coll Med, Uijongbu, South Korea; Kyungpook Natl Univ, Sch Med, Dept Psychiat, Daegu, South Korea; Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Psychiat, Busan, South Korea; Pusan Natl Univ, Yangsan Hosp, Dept Psychiat, Yangsan, South Korea; Hanyang Univ, Coll Med, Dept Psychiat, Seoul, South Korea; Kangwon Natl Univ, Sch Med, Dept Psychiat, Chunchon, South Korea; Keimyung Univ, DongSan Hosp, Dept Psychiat, Daegu, South Korea; Konyang Univ Hosp, Dept Psychiat, Daejeon, South Korea; Soonchunhyang Univ, Bucheon Hosp, Coll Med, Dept Psychiat, Bucheon, South Korea; Dajeonghan Hosp, Naju, South Korea; Chungnam Natl Univ Hosp, Dept Psychiat, Daejeon, South Korea; Kyung Hee Univ, Coll Med, Dept Neuropsychiat, Seoul, South Korea; Eulji Gen Hosp, Dept Psychiat, Seoul, South Korea; Ewha Womans Univ, Coll Med, Dept Psychiat, Seoul, South Korea; Clin Emot & Cognit Res Lab, Goyang, South Korea; Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Psychiat, Goyang, South Korea; Yeungnam Univ Hosp, Dept Psychiat, Daegu, South Korea; Korea Univ, Coll Med, Dept Psychiat, Seoul, South Korea; Korea Univ, Chronobiol Inst, Seoul, South Korea; Yong In Mental Hosp, Yongin, South Korea; Hanyang Univ, Guri Hosp, Dept Psychiat, Guri, South Korea; Wonju Severance Christian Hosp, Dept Psychiat, Wonju, South Korea; Gachon Univ, Coll Med, Gil Med Ctr, Dept Psychiat, Incheon, South Korea; Hanyang Univ, Myongji Hosp, Coll Med, Dept Psychiat, Goyang, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Psychiat, Seongnam, South Korea; Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul, South Korea; Inha Univ Hosp, Dept Psychiat, Incheon, South Korea; Mental Hlth Res Inst, NCMH, Seoul, South Korea; Konkuk Univ, Med Ctr, Dept Psychiat, Seoul, South Korea; Konkuk Univ, Sch Med, Dept Psychiat, Seoul, South Korea; Natl Hlth Insurance Serv Ilsan Hosp, Dept Psychiat, Goyang, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Psychiat, Seoul, South Korea; Catholic Univ Korea, Eunpyeong St Marys Hosp, Dept Psychiat, Coll Med, Seoul, South Korea PAIK, JONG-WOO/C-2177-2016; Lee, Heon-Jeong/K-5871-2015; Kim, Min-Hyuk/ITV-2946-2023; Lee, Seung-Yup/AAC-7198-2021; KOO, BON HOON/KOD-4275-2024; 김, 원형/HLP-6085-2023; Lee, Seung/AAI-1191-2020; Jung, Hee/J-5659-2012; Kim, Yongkang/AAC-7436-2020 57218342066; 9333810000; 57216677960; 57207957838; 59262105600; 35278955600; 59053777300; 55186354300; 8677775200; 15036290300; 57191729747; 57211573327; 35867358400; 8914975100; 57196227240; 59250792700; 12784803900; 24376890800; 54787809400; 56739411100; 57079780200; 57191711119; 16643419600; 7201867961; 55722469700; 56122910200; 55572091200; 57044163800; 55656067300; 57690228600; 55756823600; 35214770400; 59250692200; 23005959200; 7405437887; 57226003194; 36760834000; 57953626500; 7403029787 hyjung@snu.ac.kr; PSYCHIATRY INVESTIGATION PSYCHIAT INVEST 1976-3026 21 7 SCIE;SSCI PSYCHIATRY 2024 1.8 63.0 0.57 2025-05-07 1 1 Lurasidone; Efficacy; Safety; Randomized clinical trial RATING-SCALE; PHARMACOLOGY; WEIGHT Efficacy; Lurasidone; Randomized clinical trial; Safety cholesterol; glucose; high density lipoprotein cholesterol; low density lipoprotein cholesterol; lurasidone; quetiapine; triacylglycerol; adult; aged; akathisia; anxiety; anxiety disorder; Article; blood pressure; body mass; Clinical Global Impression-severity scale; connective tissue disease; constipation; diastolic blood pressure; disease duration; dizziness; drug efficacy; drug safety; female; glucose blood level; heart rate; human; major clinical study; male; mental disease; musculoskeletal disease; nausea; Positive and Negative Syndrome Scale; prevalence; psychosis; QT interval; QTc interval; schizophrenia; somnolence; tremor; vaccination; visual analog scale; waist circumference; young adult English 2024 2024-07 10.30773/pi.2024.0052 바로가기 바로가기 바로가기 바로가기
페이지 이동:

논문 데이터 용어 설명

용어 설명
WoS Web of Science. Clarivate Analytics에서 제공하는 학술 데이터베이스입니다. 해당 논문이 WoS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
SCOPUS Elsevier에서 제공하는 세계 최대 규모의 초록 및 인용 데이터베이스입니다. 해당 논문이 SCOPUS에 수록되어 있는지 여부를 표시합니다 (○: 수록됨).
Document Type 문헌의 유형을 나타냅니다. Article(원저), Review(리뷰), Proceeding Paper(학회논문), Editorial Material(편집자료), Letter(레터) 등으로 분류됩니다.
Title 논문의 제목입니다.
Abstract 논문의 초록(요약)입니다. 연구의 목적, 방법, 결과, 결론을 간략히 요약한 내용입니다.
Authors 논문의 저자 목록입니다. 공동 저자가 여러 명인 경우 세미콜론(;)으로 구분됩니다.
Affiliation 저자들의 소속 기관 정보입니다. 대학, 연구소, 기업 등 저자가 소속된 기관명이 표시됩니다.
ResearcherID (WoS) Web of Science의 고유 연구자 식별번호입니다. 동명이인을 구분하고 연구자의 업적을 정확하게 추적할 수 있습니다.
AuthorsID (SCOPUS) SCOPUS의 고유 저자 식별번호입니다. 연구자의 모든 출판물을 추적하고 관리하는 데 사용됩니다.
Journal 논문이 게재된 학술지의 정식 명칭입니다.
JCR Abbreviation Journal Citation Reports에서 사용하는 저널의 공식 약어입니다. 저널을 간략하게 표기할 때 사용됩니다.
ISSN International Standard Serial Number. 국제표준연속간행물번호로, 인쇄본 저널에 부여되는 고유 식별번호입니다.
eISSN Electronic ISSN. 전자 버전 저널에 부여되는 고유 식별번호입니다.
Volume 저널의 권(Volume) 번호입니다. 보통 연도별로 하나의 권이 부여됩니다.
Issue 저널의 호(Issue) 번호입니다. 한 권 내에서 여러 호로 나누어 출판되는 경우가 많습니다.
WoS Edition Web of Science의 에디션입니다. SCIE(Science Citation Index Expanded), SSCI(Social Sciences Citation Index), AHCI(Arts & Humanities Citation Index) 등으로 구분됩니다.
WoS Category Web of Science의 주제 분류 카테고리입니다. 저널과 논문이 속한 학문 분야를 나타냅니다.
JCR Year 해당 저널의 JCR(Journal Citation Reports) 지표가 산출된 연도입니다.
IF (Impact Factor) 저널 영향력 지수. 최근 2년간 발표된 논문이 해당 연도에 평균적으로 인용된 횟수를 나타냅니다. 저널의 학술적 영향력을 나타내는 대표적인 지표입니다.
JCR (%) 해당 카테고리에서 저널이 위치하는 상위 백분율입니다. 값이 낮을수록 우수한 저널임을 의미합니다 (예: 5%는 상위 5%를 의미).
FWCI Field-Weighted Citation Impact. 분야별 가중 인용 영향력 지수입니다. 논문이 받은 인용을 동일 분야, 동일 연도, 동일 문헌 유형의 평균과 비교한 값입니다. 1.0이 평균이며, 1.0보다 높으면 평균 이상의 인용을 받았음을 의미합니다.
FWCI UpdateDate FWCI 값이 마지막으로 업데이트된 날짜입니다. FWCI는 인용이 누적됨에 따라 주기적으로 업데이트됩니다.
WOS Citation Web of Science에서 집계된 해당 논문의 총 인용 횟수입니다.
SCOPUS Citation SCOPUS에서 집계된 해당 논문의 총 인용 횟수입니다.
Keywords (WoS) 저자가 논문에서 직접 지정한 키워드입니다. Web of Science에 등록된 저자 키워드 목록입니다.
KeywordsPlus (WoS) Web of Science에서 자동으로 추출한 추가 키워드입니다. 논문의 참고문헌 제목에서 자주 등장하는 단어들로 생성됩니다.
Keywords (SCOPUS) 저자가 논문에서 직접 지정한 키워드입니다. SCOPUS에 등록된 저자 키워드 목록입니다.
KeywordsPlus (SCOPUS) SCOPUS에서 자동으로 추출하거나 추가한 색인 키워드입니다.
Language 논문이 작성된 언어입니다. 대부분 English이며, 그 외 다양한 언어로 작성된 논문이 포함될 수 있습니다.
Publication Year 논문이 출판된 연도입니다.
Publication Date 논문의 정확한 출판 날짜입니다 (년-월-일 형식).
DOI Digital Object Identifier. 디지털 객체 식별자로, 논문을 고유하게 식별하는 영구적인 식별번호입니다. 이를 통해 논문의 온라인 위치를 찾을 수 있습니다.